On the basis of accumulating evidence, ALDH, defined as a superfamily of enzymes that participate in the metabolism of aldehyde derivatives, has been used as a specific biomarker to identify CSCs in a large number of cancers (Ginestier et al., 2007; Feldmann et al., 2007; Marchitti et al., 2008). The gene discussed is LDHA; the disease is cancer.